Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines

Journal of Virology

Volumn 84, Issue 14, 2010, Pages 6966-6977

  Watanabe, Masaaki ^a   Nakahata, Shingo ^a   Hamasaki, Makoto ^a   Saito, Yusuke ^a   Kawano, Yohei ^a   Hidaka, Tomonori ^a   Yamashita, Kiyoshi ^a   Umeki, Kazumi ^a   Taki, Tomohiko ^b   Taniwaki, Masafumi ^b   Okayama, Akihiko ^a   Morishita, Kazuhiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; TAX PROTEIN;

ARTICLE; EPIGENETICS; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA;

ADULT; CELL CYCLE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MICROARRAY ANALYSIS; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77953742426     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00073-10     Document Type: Article

References (40)

1. Akagi, T., H. Ono, and K. Shimotohno. 1995. Characterization of T cells immortalized by Tax1 of human T-cell leukemia virus type 1. Blood 86:4243-4249.
2. Cereseto, A., R. Washington Parks, E. Rivadeneira, and G. Franchini. 1999. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Oncogene 18:2441-2450.
3. Claus, R., and M. Lubbert. 2003. Epigenetic targets in hematopoietic malignancies. Oncogene 22:6489-6496.
4. de La Fuente, C., L. Deng, F. Santiago, L. Arce, L. Wang, and F. Kashanchi. 2000. Gene expression array of HTLV type 1-infected T cells: Up-regulation of transcription factors and cell cycle genes. AIDS Res. Hum. Retroviruses 16:1695-1700.
5. de La Fuente, C., F. Santiago, S. Y. Chong, L. Deng, T. Mayhood, P. Fu, D. Stein, T. Denny, F. Coffman, N. Azimi, R. Mahieux, and F. Kashanchi. 2000. Overexpression of p21waf1 in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/Cdk2. J. Virol. 74:7270-7283.
6. Dewan, M. Z., N. Takamatsu, T. Hidaka, K. Hatakeyama, S. Nakahata, J. Fujisawa, H. Katano, N. Yamamoto, and K. Morishita. 2008. Critical role for TSLC1 expression in the growth and organ infiltration of adult T-cell leukemia cells in vivo. J. Virol. 82:11958-11963.
7. Fang, J. Y., and Y. Y. Lu. 2002. Effects of histone acetylation and DNA methylation on p21 (WAF1) regulation. World J. Gastroenterol. 8:400-405.
8. Fukuda, R. I., K. Tsuchiya, K. Suzuki, K. Itoh, J. Fujita, A. Utsunomiya, and T. Tsuji. 2009. Human T-cell leukemia virus type I Tax down-regulates the expression of phosphatidylinositol 3,4,5-trisphosphate inositol phosphatases via the NF-κB pathway. J. Biol. Chem. 284:2680-2689.
9. Harhaj, E. W., L. Good, G. Xiao, and S. C. Sun. 1999. Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene 18:1341-1349.
10. Hidaka, T., S. Nakahata, K. Hatakeyama, M. Hamasaki, K. Yamashita, T. Kohno, Y. Arai, T. Taki, K. Nishida, A. Okayama, Y. Asada, R. Yamaguchi, H. Tsubouchi, J. Yokota, M. Taniwaki, Y. Higashi, and K. Morishita. 2008. Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia/lymphoma. Blood 112:383-393.
11. Jiemjit, A., T. E. Fandy, H. Carraway, K. A. Bailey, S. Baylin, J. G. Herman, and S. D. Gore. 2008. p21(WAF1/CIP1) induction by 5-azacytosine nucleosides requires DNA damage. Oncogene 27:3615-3623.
12. Katrin, S., and G. Ralph. 2007. Human T cell leukemia virus type 1 Tax-induced signals in cell survival, proliferation, and transformation. Signal Transduct. 7:34-52.
13. Kehn, K., L. Deng, C. de la Fuente, K. Strouss, K. Wu, A. Maddukuri, S. Baylor, R. Rufner, A. Pumfery, M. E. Bottazzi, and F. Kashanchi. 2004. The role of cyclin D2 and p21/waf1 in human T-cell leukemia virus type 1 infected cells. Retrovirology 1:6.
14. Koiwa, T., A. Hamano-Usami, T. Ishida, A. Okayama, K. Yamaguchi, S. Kamihira, and T. Watanabe. 2002. 5′-Long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J. Virol. 76:9389-9397.
15. 1 arrest. Nat. Med. 8:1153-1160.
16. Reference deleted.
17. Matsuoka, M., and K. T. Jeang. 2007. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer. 7:270-280.
18. Peloponese, J. M., Jr., and K. T. Jeang. 2006. Role for Akt/protein kinase B and activator protein-1 in cellular proliferation induced by the human T-cell leukemia virus type 1 tax oncoprotein. J. Biol. Chem. 281:8927-8938.
19. Pise-Masison, C. A., M. Radonovich, R. Mahieux, P. Chatterjee, C. Whiteford, J. Duvall, C. Guillerm, A. Gessain, and J. N. Brady. 2002. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res. 62:3562-3571.
20. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U. S. A. 77:7415-7419.
21. Proietti, F. A., A. B. Carneiro-Proietti, B. C. Catalan-Soares, and E. L. Murphy. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058-6068.
22. Raizis, A. M., F. Schmitt, and J. P. Jost. 1995. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. Anal. Biochem. 226:161-166.
23. Roman-Gomez, J., J. A. Castillejo, A. Jimenez, M. G. Gonzalez, F. Moreno, C. Rodriguez Mdel, M. Barrios, J. Maldonado, and A. Torres. 2002. 5′ CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia. Blood 99:2291-2296.
24. Sasaki, H., I. Nishikata, T. Shiraga, E. Akamatsu, T. Fukami, T. Hidaka, Y. Kubuki, A. Okayama, K. Hamada, H. Okabe, Y. Murakami, H. Tsubouchi, and K. Morishita. 2005. Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia. Blood 105:1204-1213.
25. Seiki, M., S. Hattori, Y. Hirayama, and M. Yoshida. 1983. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl. Acad. Sci. U. S. A. 80:3618-3622.
26. Shin, I., F. M. Yakes, F. Rojo, N. Y. Shin, A. V. Bakin, J. Baselga, and C. L. Arteaga. 2002. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat. Med. 8:1145-1152.
27. Shin, J. Y., H. S. Kim, J. Park, J. B. Park, and J. Y. Lee. 2000. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. Cancer Res. 60:262-265.
28. Siegel, R. S., R. B. Gartenhaus, and T. M. Kuzel. 2001. Human T-cell lymphotropic-I-associated leukemia/lymphoma. Curr. Treat. Options Oncol. 2:291-300.
29. Tajima, K. 1990. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int. J. Cancer 45:237-243.
30. Takeda, S., M. Maeda, S. Morikawa, Y. Taniguchi, J. Yasunaga, K. Nosaka, Y. Tanaka, and M. Matsuoka. 2004. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int. J. Cancer. 109:559-567.
31. Tanaka, G., A. Okayama, T. Watanabe, S. Aizawa, S. Stuver, N. Mueller, C. C. Hsieh, and H. Tsubouchi. 2005. The clonal expansion of human T lymphotropic virus type 1-infected T cells: a comparison between seroconverters and long-term carriers. J. Infect. Dis. 191:1140-1147.
32. Taniguchi, Y., K. Nosaka, J. Yasunaga, M. Maeda, N. Mueller, A. Okayama, and M. Matsuoka. 2005. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2:64.
33. kip1 expression. J. Virol. 79:14069-14078.
34. Viglietto, G., M. L. Motti, P. Bruni, R. M. Melillo, A. D'Alessio, D. Califano, F. Vinci, G. Chiappetta, P. Tsichlis, A. Bellacosa, A. Fusco, and M. Santoro. 2002. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8:1136-1144.
35. Winters, Z. E., R. D. Leek, M. J. Bradburn, C. J. Norbury, and A. L. Harris. 2003. Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis. Breast Cancer Res. 5:R242-R249.
36. Xia, W., J. S. Chen, X. Zhou, P. R. Sun, D. F. Lee, Y. Liao, B. P. Zhou, and M. C. Hung. 2004. Phosphorylation/cytoplasmic localization of p21Cip1/WAF1 is associated with HER2/neu overexpression and provides a novel combination predictor for poor prognosis in breast cancer patients. Clin. Cancer Res. 10:3815-3824.
37. Yamada, Y., M. Tomonaga, H. Fukuda, S. Hanada, A. Utsunomiya, M. Tara, M. Sano, S. Ikeda, K. Takatsuki, M. Kozuru, K. Araki, F. Kawano, M. Niimi, K. Tobinai, T. Hotta, and M. Shimoyama. 2001. A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br. J. Haematol. 113:375-382.
38. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U. S. A. 79:2031-2035.
39. Zhou, B. P., Y. Liao, W. Xia, B. Spohn, M. H. Lee, and M. C. Hung. 2001. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:245-252.
40. Zhu, W. G., K. Srinivasan, Z. Dai, W. Duan, L. J. Druhan, H. Ding, L. Yee, M. A. Villalona-Calero, C. Plass, and G. A. Otterson. 2003. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21 (Cip1) promoter. Mol. Cell. Biol. 23:4056-4065.